The Pfizer logo is seen at their world headquarters in New York.
Andrew Kelly/Reuters
Pfizer Inc announced plans on Wednesday to reorganize into three units, separating its consumer health care business that the U.S. drugmaker has been trying to sell since last year.
The company said it is still looking for options for the lower-margin, non-core consumer health care business that makes products ranging from painkiller Advil to lip balms and is worth about $15 billion.
Given the lack of urgency, management is being rational about its divestiture, BMO Capital Markets analyst Alex Arfaei said, adding the new structure will help Pfizer maintain its options for the business.
The news comes a da…
Read the full article at: https://www.theglobeandmail.com/business/international-business/us-business/article-pfizer-to-restructure-business-into-three-units/